Short Reads

Premium

Helicos' Q4 Grant Revenues Double; Expects Instrument Revenue in '09

Helicos BioSciences' fourth-quarter grant revenues increased to $206,000 from $117,000 year over year, the firm reported in a filing with the US Securities and Exchange Commission this week.

The firm also reported its first-ever product revenue, totaling $36,000 for the three-month period ended Dec. 31, 2008. The company said in the filing that it expects to "recognize revenue from one of our initial 2008 instrument shipments in 2009."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.